Original Research

Published on 04 Dec 2023

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

in Molecular and Cellular Oncology

Rao Prabhala
William E. Pierceall
Mehmet Samur
Lakshmi B. Potluri
Kevin Hong
Teresa Peluso
Srikanth Talluri
Angela Wang
Aishwarya Katiki
Sahan D. Vangala

Frontiers in Oncology

doi 10.3389/fonc.2023.1271807

2,109 views
3 citations

Original Research

Published on 30 Nov 2023

Serum exosomal circCCDC66 as a potential diagnostic and prognostic biomarker for pituitary adenomas

in Molecular and Cellular Oncology

Xiao Yue
Fengming Lan
Weiping Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1268778

1,197 views
2 citations

Review

Published on 30 Nov 2023

The development of cancers research based on mitochondrial heat shock protein 90

in Molecular and Cellular Oncology

Yuchu Xiang
Xudong Liu
Qi Sun
Kuo Liao
Xiaohan Liu
Zihui Zhao
Lishuang Feng
Yan Liu
Bo Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1296456

2,619 views
4 citations

Editorial

Published on 29 Nov 2023

Editorial: Molecular and cellular mechanisms for cancer therapy resistance

in Molecular and Cellular Oncology

Anna Martina Battaglia
Emanuele Giorgio
Lavinia Petriaggi
Flavia Biamonte
Majid Momeny

Frontiers in Oncology

doi 10.3389/fonc.2023.1340318

1,016 views
1 citation

Editorial

Published on 23 Nov 2023

Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer

in Molecular and Cellular Oncology

Diletta Favero
Daniele Generali
Francesco Schettini

Frontiers in Oncology

doi 10.3389/fonc.2023.1337315

860 views

Editorial

Published on 23 Nov 2023

Editorial: Hallmark of cancer: sustained proliferative signalling

in Molecular and Cellular Oncology

Fabio Ciccarone
Maria Rosa Ciriolo

Frontiers in Oncology

doi 10.3389/fonc.2023.1328827

2,132 views

Original Research

Published on 23 Nov 2023

Structural characterization of human de novo protein NCYM and its complex with a newly identified DNA aptamer using atomic force microscopy and small-angle X-ray scattering

in Molecular and Cellular Oncology

Seigi Yamamoto
Fumiaki Kono
Kazuma Nakatani
Miwako Hirose
Katsunori Horii
Yoshitaka Hippo
Taro Tamada
Yusuke Suenaga
Tatsuhito Matsuo

Frontiers in Oncology

doi 10.3389/fonc.2023.1213678

2,821 views
4 citations

Review

Published on 22 Nov 2023

New insights into fibrotic signaling in hepatocellular carcinoma

in Molecular and Cellular Oncology

Liang Shan
Fengling Wang
Weiju Xue
Dandan Zhai
Jianjun Liu
Xiongwen Lv

Frontiers in Oncology

doi 10.3389/fonc.2023.1196298

6,425 views
1 citation

Systematic Review

Published on 21 Nov 2023

Research trends and hotspots in prostate cancer associated exosome: a bibliometric analysis

in Molecular and Cellular Oncology

Zhengjia Zhu
Yingjian Zhou
Hao Li
Wenchao Xu
Tao Wang
Jihong Liu
Hongyang Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1270104

2,910 views
2 citations

Editorial

Published on 17 Nov 2023

Editorial: Molecular regulation of tumor cells migration and metastatic growth

in Molecular and Cellular Oncology

Michelle L. Matter
Vasiliki Gkretsi

Frontiers in Oncology

doi 10.3389/fonc.2023.1329053

777 views
1 citation

Review

Published on 14 Nov 2023

AHNAKs roles in physiology and malignant tumors

in Molecular and Cellular Oncology

Shusen Zhang
Zhigang Cai
Hui Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1258951

3,490 views
2 citations

Hypothesis and Theory

Published on 09 Nov 2023

The permissive binding theory of cancer

in Molecular and Cellular Oncology

Caroline M. Weisman

Frontiers in Oncology

doi 10.3389/fonc.2023.1272981

1,919 views

Review

Published on 07 Nov 2023

CD147: an integral and potential molecule to abrogate hallmarks of cancer

in Molecular and Cellular Oncology

Alphonce M. K. Nyalali
Angela U. Leonard
Yongxiang Xu
Huayu Li
Junlin Zhou
Xinrui Zhang
Tibera K. Rugambwa
Xiaohan Shi
Feng Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1238051

7,652 views
13 citations

Review

Published on 07 Nov 2023

Evolutionary reversion in tumorigenesis

in Molecular and Cellular Oncology

Yosuke Nagahata
Hiroshi Kawamoto

Frontiers in Oncology

doi 10.3389/fonc.2023.1282417

1,463 views
2 citations

Brief Research Report

Published on 07 Nov 2023

m6A regulates breast cancer proliferation and migration through stage-dependent changes in Epithelial to Mesenchymal Transition gene expression

in Molecular and Cellular Oncology

Mohammed G. Dorgham
Brittany A. Elliott
Christopher L. Holley
Kyle D. Mansfield

Frontiers in Oncology

doi 10.3389/fonc.2023.1268977

1,485 views

Original Research

Published on 01 Nov 2023

CircDDX17 inhibits invasive progression of pituitary adenomas by sponging miR-1279 and regulating CADM2 expression

in Molecular and Cellular Oncology

Xiao Yue
Fengming Lan
Weiping Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1268644

1,183 views
1 citation

Navigation group

Articles

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

Serum exosomal circCCDC66 as a potential diagnostic and prognostic biomarker for pituitary adenomas

The development of cancers research based on mitochondrial heat shock protein 90

Editorial: Molecular and cellular mechanisms for cancer therapy resistance

Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer

Editorial: Hallmark of cancer: sustained proliferative signalling

Structural characterization of human de novo protein NCYM and its complex with a newly identified DNA aptamer using atomic force microscopy and small-angle X-ray scattering

New insights into fibrotic signaling in hepatocellular carcinoma

Research trends and hotspots in prostate cancer associated exosome: a bibliometric analysis

Editorial: Molecular regulation of tumor cells migration and metastatic growth

AHNAKs roles in physiology and malignant tumors

The permissive binding theory of cancer

CD147: an integral and potential molecule to abrogate hallmarks of cancer

Evolutionary reversion in tumorigenesis

m6A regulates breast cancer proliferation and migration through stage-dependent changes in Epithelial to Mesenchymal Transition gene expression

CircDDX17 inhibits invasive progression of pituitary adenomas by sponging miR-1279 and regulating CADM2 expression